2023 annual financial data
Revelation Biosciences 2023 Operating margin
Revelation Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -8,656,664 USD and net income was -120,254 USD.
Operating cash flow was -7,286,286 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,656,664 USD
- Net income
- -120,254 USD
- Operating cash flow
- -7,286,286 USD